News & Updates
Novavax COVID-19 Vaccine, Adjuvanted Booster Now Authorized for 18+
Background On October 19, 2022, the U.S Food and Drug Administration re-issued a letter of authorization, in its entirety, to authorize the use of Novavax COVID19 Vaccine, Adjuvanted as a...
Monkeypox Virus Guidance: Infection Control and Prevention in Health Care Settings
Background Standard Precautions should be applied for all patient care, including for patients with suspected monkeypox. If a patient seeking care is suspected to have monkeypox, infection prevention and control...
Updated Infection Prevention and Control Recommendations for Health Care Personnel During the Coronavirus Disease (COVID-19) Pandemic
Background On September 23, 2022, the Centers for Disease Control and Prevention (CDC) and Centers for Medicare and Medicaid Services (CMS) updated their infection control guidance for the health care...
Monkeypox Virus Guidance for Health Care Providers-Clinical Considerations for Treatment, Pain Management and Severe Manifestations of Monkeypox among Immunocompromised Persons
Background Since May 2022, more than 25,000 monkeypox cases have been identified in the United States. Patients with monkeypox benefit from supportive care and pain control that is implemented early...
Novavax COVID-19 Vaccine, Adjuvanted, Now Recommended by CDC for 12+ Years
Background: On July 13, 2022, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine, Adjuvanted, in individuals 18 years of age...
JYNNEOS Vaccine Authorized by the FDA for Emergency Use Authorization
Background: In 2019, the JYNNEOS vaccine was approved by the U.S. Food and Drug Administration (FDA) for the prevention of smallpox and monkeypox disease in individuals aged 18 years and...
Monkeypox Virus Guidance: Infection Control and Prevention for Patients in a Home Setting
Background People with monkeypox who do not require hospitalization should isolate at home. Patients with known or suspected monkeypox should be instructed to isolate themselves and avoid contact with other...
Bivalent COVID-19 Booster Vaccine Recommended for 12 Years and Older
Background: On August 31, 2022, the U.S. Food and Drug Administration (FDA) issued amended Emergency Use Authorizations (EUAs) to both Moderna and Pfizer-BioNTech to authorize their bivalent formulations of the...
Updated Guidance: Isolation and Precautions for People with COVID-19
Background The Centers for Disease Control and Prevention (CDC) updated their isolation guidance on August 11, 2022, for persons with COVID-19.1 Individuals with COVID-19 can spread the virus to others...
Monkeypox Virus Vaccine Guidance and Recommendations
Background According to the Centers for Disease Control and Prevention (CDC), since monkeypox virus is closely related to the virus that causes smallpox, the smallpox vaccine can protect people from...
Moderna COVID-19 Vaccine Approved for Children and Adolescents 6-17 years
Background: On June 14, 2022, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to recommend the authorization and use of the Moderna mRNA COVID-19 vaccine, for children and...
Pediatric COVID-19 Vaccines Recommended for Children Aged 6 mo – 5 years
Background: On June 15, 2022, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend the authorization of both the Moderna COVID-19 vaccine two-dose primary series for...